Liver Transplant Clinical Trials 2023

Liver Transplant Clinical Trials 2023

Liver Transplant research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in liver transplant clinical trials today.

Liver Transplant Clinical Trials

Here are the 6 most popular medical studies for liver transplant

Popular filter options for liver transplant trials

Non-alcoholic Fatty Liver Disease Clinical Trials

View 9 Non-alcoholic Fatty Liver Disease medical studies.

Portal Hypertension Clinical Trials

View 9 Portal Hypertension medical studies.

Liver Transplant Clinical Trials With No Placebo

View 60 liver transplant medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to liver transplant

What are the top hospitals conducting liver transplant research?

When it comes to cutting-edge clinical trials in liver transplantation, several prestigious hospitals are leading the way. In Toronto, the University Health Network is at the forefront with five ongoing liver transplant trials. This renowned institution is dedicated to advancing the field of liver transplantation and improving patient outcomes through rigorous research. In Chicago, Northwestern University is making significant strides as well, currently conducting four active trials focused on liver transplants. With a commitment to innovation and excellence in healthcare, this hospital aims to revolutionize the field of liver transplantation. Similarly, the University of Pennsylvania in Philadelphia has also invested in four active clinical trials for liver transplants, demonstrating their dedication to finding new solutions for patients awaiting life-saving procedures.

Furthermore,Toronto General Hospital shares its commitment by participating in three ongoing clinical trials for liver transplantations while continuing its legacy of providing state-of-the-art medical care.These collective efforts ensure that patients facing critical challenges have access to pioneering treatments and potential breakthroughs.

On the other side of North America,in San Francisco,the University of California presents itself as an invaluable contributor where researchers actively engage incarrying outthree distinctlivertransplanttrials;their devotion towards exploring innovative approaches manifests their unwavering dedication towards transforming lives through these groundbreaking studies.

These top-tier institutions serve not only as pillars within their respective communities but also exemplify how collaboration between medical professionals can lead to transformative advancements in organ transplantation.The expansive groundwork laid by such hospitals paves a path toward improved techniques,survival rates,and overall qualityof lifefor individuals suffering from end-stage liver disease.Every step taken towards enhancing our understanding and refining treatment options provides hope for individuals awaiting life-altering transplants—ultimately changing countless lives forever

Which are the best cities for liver transplant clinical trials?

When it comes to liver transplant clinical trials, several cities emerge as top contenders in advancing research and treatment options. New york, with 11 active trials, focuses on studies such as HIVD+/R+, Telemetric Intervention, and the VitaSmart Liver Machine Perfusion System. Chicago follows closely behind with 10 ongoing trials exploring interventions like "Liver FrailTy" intervention (LIFT) among others. Toronto also plays a significant role with its 9 active trials investigating live donor liver transplantation, PET MRI, and Deceased donor Liver Transplantation. These cities showcase remarkable dedication to pushing the boundaries of liver transplant research and offering hope for patients in need of this life-saving procedure.

Which are the top treatments for liver transplant being explored in clinical trials?

Clinical trials for liver transplant treatments are yielding promising results, with several notable contenders taking the spotlight. One of the leading options is Apabetalone, which has shown potential in improving outcomes after liver transplantation. Another noteworthy treatment being explored is FT-4202, which aims to address complications related to sickle cell disease post-transplantation. Additionally, the drug Maralixibat is under investigation for its potential benefits in preventing bile acid-related complications following a liver transplant. With ongoing research and advancements, these treatments offer hope for enhancing patient outcomes in liver transplantation procedures.

What are the most recent clinical trials for liver transplant?

Exciting progress is being made in the field of liver transplant, with recent clinical trials exploring new possibilities and potential treatments. One such trial investigates the use of semaglutide pen injector, currently in Phase 2. This innovative approach aims to improve outcomes for liver transplant patients. Another study focuses on combining atezolizumab and bevacizumab in a Phase 4 trial, seeking to optimize immunosuppressive strategies for successful liver transplantation. Additionally, fenofibrate has shown promise as a treatment option through its ongoing Phase 2 trial. As researchers continue their efforts to enhance patient care, these advancements offer hope for individuals undergoing or awaiting a liver transplant procedure.

What liver transplant clinical trials were recently completed?

Recently completed clinical trials in the field of liver transplantation have yielded important findings, bringing hope to patients awaiting this life-saving procedure.